LGT Fund Management Co Ltd. Acquires 766 Shares of CME Group Inc. (NASDAQ:CME)

LGT Fund Management Co Ltd. boosted its holdings in shares of CME Group Inc. (NASDAQ:CMEFree Report) by 17.2% during the 4th quarter, Holdings Channel reports. The firm owned 5,222 shares of the financial services provider’s stock after buying an additional 766 shares during the period. LGT Fund Management Co Ltd.’s holdings in CME Group were worth $1,213,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Meyer Handelman Co. bought a new stake in CME Group in the 4th quarter worth approximately $6,144,000. Spire Wealth Management increased its stake in CME Group by 37.4% in the 4th quarter. Spire Wealth Management now owns 1,320 shares of the financial services provider’s stock worth $307,000 after acquiring an additional 359 shares during the last quarter. AEGON ASSET MANAGEMENT UK Plc increased its stake in CME Group by 19.3% in the 4th quarter. AEGON ASSET MANAGEMENT UK Plc now owns 326,098 shares of the financial services provider’s stock worth $75,730,000 after acquiring an additional 52,862 shares during the last quarter. Bank of Montreal Can increased its stake in CME Group by 41.8% in the 3rd quarter. Bank of Montreal Can now owns 1,028,090 shares of the financial services provider’s stock worth $224,432,000 after acquiring an additional 303,169 shares during the last quarter. Finally, Geode Capital Management LLC increased its stake in CME Group by 1.8% in the 3rd quarter. Geode Capital Management LLC now owns 8,284,745 shares of the financial services provider’s stock worth $1,823,964,000 after acquiring an additional 142,692 shares during the last quarter. Institutional investors own 87.75% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms have issued reports on CME. Keefe, Bruyette & Woods lifted their price objective on CME Group from $256.00 to $257.00 and gave the stock a “market perform” rating in a research note on Friday, February 14th. Citigroup downgraded CME Group from a “buy” rating to a “neutral” rating and cut their target price for the company from $255.00 to $250.00 in a research report on Monday, January 6th. Barclays boosted their target price on CME Group from $257.00 to $263.00 and gave the company an “equal weight” rating in a research report on Thursday, February 13th. Morgan Stanley boosted their target price on CME Group from $256.00 to $263.00 and gave the company an “equal weight” rating in a research report on Wednesday, February 19th. Finally, Piper Sandler boosted their target price on CME Group from $250.00 to $258.00 and gave the company an “overweight” rating in a research report on Tuesday, January 7th. Four investment analysts have rated the stock with a sell rating, eight have issued a hold rating and three have given a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $236.13.

Check Out Our Latest Analysis on CME Group

CME Group Price Performance

CME opened at $256.88 on Tuesday. The business has a fifty day moving average of $238.80 and a 200 day moving average of $229.58. CME Group Inc. has a 52-week low of $190.70 and a 52-week high of $257.78. The company has a quick ratio of 1.02, a current ratio of 1.01 and a debt-to-equity ratio of 0.10. The stock has a market cap of $92.57 billion, a P/E ratio of 26.56, a PEG ratio of 6.76 and a beta of 0.57.

CME Group (NASDAQ:CMEGet Free Report) last issued its earnings results on Wednesday, February 12th. The financial services provider reported $2.52 earnings per share for the quarter, topping the consensus estimate of $2.46 by $0.06. CME Group had a return on equity of 13.62% and a net margin of 57.52%. As a group, sell-side analysts anticipate that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, March 26th. Shareholders of record on Friday, March 7th will be issued a $1.25 dividend. This represents a $5.00 annualized dividend and a dividend yield of 1.95%. This is a boost from CME Group’s previous quarterly dividend of $1.15. The ex-dividend date is Friday, March 7th. CME Group’s dividend payout ratio is currently 51.71%.

CME Group declared that its board has approved a stock buyback program on Thursday, December 5th that authorizes the company to repurchase $3.00 billion in shares. This repurchase authorization authorizes the financial services provider to repurchase up to 3.4% of its shares through open market purchases. Shares repurchase programs are often an indication that the company’s management believes its stock is undervalued.

Insiders Place Their Bets

In other CME Group news, insider Julie Winkler sold 11,592 shares of the company’s stock in a transaction on Thursday, February 13th. The stock was sold at an average price of $249.17, for a total value of $2,888,378.64. Following the completion of the sale, the insider now directly owns 21,885 shares in the company, valued at approximately $5,453,085.45. This represents a 34.63 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Hilda Harris Piell sold 3,984 shares of the business’s stock in a transaction on Thursday, February 27th. The stock was sold at an average price of $250.47, for a total value of $997,872.48. Following the completion of the transaction, the insider now directly owns 27,046 shares of the company’s stock, valued at approximately $6,774,211.62. The trade was a 12.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 0.30% of the company’s stock.

CME Group Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Recommended Stories

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.